ASAnita M. Saran

Anita M. Saran

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Anita M. Saran has a total of 7 co-authors. Here are the top co-authors by number of shared publications:

  • Barry I. Freedman

    Department of Internal Medicine/Nephrology, Wake Forest University School of Medicine, Winston-Salem, N.C., USA

    1 shared publication
  • Donald W. Bowden

    Department of Internal Medicine/Nephrology, Wake Forest University School of Medicine, Winston-Salem, N.C., USA

    1 shared publication
  • Fang-Chi Hsu

    Department of Biostatistical Sciences, Wake Forest University School of Medicine, Winston-Salem, N.C., USA

    1 shared publication
  • John Jeffrey Carr

    Vanderbilt University Medical Center

    1 shared publication
  • Kurt K. Lohman

    Department of Biostatistical Sciences, Wake Forest University School of Medicine, Winston-Salem, N.C., USA

    1 shared publication
  • Lynne E. Wagenknecht

    Department of Epidemiology and Prevention, Wake Forest University School of Medicine, Winston-Salem, N.C., USA

    1 shared publication

Latest Publications

  • Open Access

    Cardiovascular disease in chronic kidney disease

    by Anita M. Saran, Thomas D. DuBose

    The presence of kidney disease, manifested by low glomerular filtration rates (GFR) and/or large amounts of protein in the urine, is independently associated with increased rates of cardiovascular disease (CVD). The severity of kidney disease is associated with graded increases in risk for CVD and death. Chronic kidney disease (CKD) should be recognized and treatment initiated early to maximize the chances for slowing nephropathy progression and reducing proteinuria. We recommend screening for CKD in all patients with CVD, including computing an estimated GFR and evaluating for proteinuria using a spot urine albumin:creatinine ratio. Aggressive management of traditional cardiovascular risk factors should be employed in this high-risk population, specifically rigorous hypertension control (including the use of angiotensin-converting enzyme inhibitors (ACEI)/angiotensin receptor blocking agents (ARB)), management of hyperglycemia, hyperlipidemia and smoking cessation. Further studies are needed to identify the unique renal failure-related (non-traditional) risk factors that contribute to accelerated atherosclerosis in this population and performance of randomized trials to assess the effects of cardiovascular interventions in individuals with CKD.


  • Kidney Volume Associations with Subclinical Renal and Cardiovascular Disease: The Diabetes Heart Study

    by Anita M. Saran, Fang-Chi Hsu, Kurt K. Lohman, J. Jeffrey Carr, Donald W. Bowden, Lynne E. Wagenknecht, Barry I. Freedman

    Background: The prognostic significance of total kidney volume (TKV) in subjects with type 2 diabetes mellitus (T2DM) is unknown. Methods: One hundred and seventy unrelated Caucasians with T2DM underwent multidetector-row computed tomography of the neck, chest, and abdomen to measure calcified plaque in the coronary artery (CorCP), carotid artery (CarCP), and infrarenal aorta (AorCP). Spearman’s rank correlation coefficients were used to assess associations between TKV and subclinical renal and cardiovascular disease. Partial correlation coefficients were computed to adjust for the potential confounding effects of age, sex, body mass index, glomerular filtration rate (GFR), diabetes duration, and hemoglobin A1c. Values are expressed as mean ± SD (median in parentheses). Results: The study group (51% female) had a mean age of 62.9 ± 8.5 (62.3) years, a T2DM duration of 11.5 ± 6.8 (10.0) years, a urinary albumin:creatinine ratio of 109.9 ± 396 (17.6) mg/g, a GFR of 63.8 ± 12.8 (63.2) ml/min, a TKV of 272.4 ± 69.7 (261.9) cm3, CorCP 2,170 ± 3,394 (653), CarCP 374 ± 673 (104), AorCP 14,569 ± 17,480 (8,370), and a carotid artery intima-media thickness of 0.70 ± 0.14 (0.68) mm. Adjusting for age, sex, body mass index, diabetes duration, GFR, and hemoglobin A1c, the TKV was significantly associated with AorCP (r = 0.20, p = 0.016), but not with CorCP, CarCP, or carotid artery intima-media thickness (all p ≧ 0.25). No significant associations were detected between TKV and blood pressure or albuminuria. Conclusions: In Caucasians with T2DM, TKV and calcified atherosclerotic plaque in the infrarenal abdominal aorta are positively associated. Common mechanisms linking renal matrix deposition with aortic atherosclerosis may underlie this association and require further study.